Gene · 7832
Papers2,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity. | BMC Cancer | 2023 | 36997866 | PubTator, text mining | PubMed |
| CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth. | Cell Rep | 2023 | 36995937 | PubTator, text mining | PubMed |
| Therapeutic Potential of Luteolin on Cancer. | Vaccines (Basel) | 2023 | 36992138 | PubTator, text mining | PubMed |
| Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination. | Mol Cancer | 2023 | 36991428 | PubTator, text mining | PubMed |
| [Clinical characteristics and prognosis of primary and secondary diffuse large B-cell lymphoma of the pancreas]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 36987724 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma. | J Pers Med | 2023 | 36983658 | PubTator, text mining | PubMed |
| Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. | Int J Mol Sci | 2023 | 36982678 | PubTator, text mining | PubMed |
| Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review. | Cancers (Basel) | 2023 | 36980718 | PubTator, text mining | PubMed |
| Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301. | Cancers (Basel) | 2023 | 36980623 | PubTator, text mining | PubMed |
| Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC. | Biomedicines | 2023 | 36979675 | PubTator, text mining | PubMed |
| Exosomes: The role in mammalian reproductive regulation and pregnancy-related diseases. | Front Physiol | 2023 | 36969587 | PubTator, text mining | PubMed |
| Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers. | iScience | 2023 | 36968082 | PubTator, text mining | PubMed |
| Role of the antineoplastic drug bleomycin based on toxicogenomic-DNA damage inducing (TGx-DDI) genomic biomarkers data: A meta-analysis. | Pak J Med Sci | 2023 | 36950431 | PubTator, text mining | PubMed |
| Erythrocyte miRNA-92a-3p interactions with PfEMP1 as determinants of clinical malaria. | Funct Integr Genomics | 2023 | 36941394 | PubTator, text mining | PubMed |
| PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis. | Technol Cancer Res Treat | 2023 | 36927233 | PubTator, text mining | PubMed |
| Roles of lncRNAs in childhood cancer: Current landscape and future perspectives. | Front Oncol | 2023 | 36923440 | PubTator, text mining | PubMed |
| Exosomal miR-93-5p as an important driver of bladder cancer progression. | Transl Androl Urol | 2023 | 36915886 | PubTator, text mining | PubMed |
| The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice. | Int J Mol Sci | 2023 | 36901727 | PubTator, text mining | PubMed |
| LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features. | Cells | 2023 | 36899941 | PubTator, text mining | PubMed |
| Integrated analysis of competitive endogenous RNA networks in elder patients with non-small cell lung cancer. | Medicine (Baltimore) | 2023 | 36897674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7832/papers?page=17